Skip to main navigation Skip to search Skip to main content

OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial

  • M. S. De Souza*
  • , R. Trichavaroj
  • , A. Schuetz
  • , W. Chuenarom
  • , Y. Phuang-ngem
  • , S. Jongrakthaitae
  • , S. Ratto-Kim
  • , S. Nitayaphan
  • , L. Dally
  • , S. Rerks-Ngam
  • , J. Tartaglia
  • , D. Francis
  • , N. L. Michael
  • , R. M. Paris
  • , J. H. Kim
  • *Corresponding author for this work

Research output: Contribution to journalComment/debate

1 Scopus citations
Original languageEnglish
Article number1742
Pages (from-to)O52
JournalRetrovirology
Volume6
Issue numberSUPPL. 3
DOIs
StatePublished - 22 Oct 2009

Fingerprint

Dive into the research topics of 'OA07-04 LB. Immunogenicity of ALVAC-HIV® (vCP1521) and AIDSVAX® B/E prime boose vaccination in RV144, the Thai Phase III HIV vaccine trial'. Together they form a unique fingerprint.

Cite this